ams Wins Federal Funding in Austria to Bolster Pandemic Control Through a Highly-accurate, Cloud-connected Lateral Flow Test ...
December 01 2020 - 11:30AM
Dow Jones News
ams (SIX: AMS), a leading worldwide supplier of high performance
sensor solutions, announces that it has been awarded funding by the
Austrian Federal Ministries for Transport, Innovation, and
Technology, and for Digital and Economic Affairs, to speed
development of a cloud-connected, highly-sensitive, accurate and
unique Lateral Flow Test (LFT) to be used in the fight against the
SARS-CoV-2 (COVID-19) virus.
This press release features multimedia. View the full release
here: https://www.businesswire.com/news/home/20201201005556/en/
ams press picture - EUREKA copyright: ams AG (Graphic: Business
Wire)
The solution is based on the ams spectral sensor AS7341L and
offers results for pandemic control in around 15 minutes, for
example, at the point of care, at home, schools, airports,
businesses, care facilities, and wherever needed. With the ambition
to detect the virus at earlier stages of infection, even before
symptoms have appeared, a highly-sensitive ams spectral sensor is
utilized to read out each LFT objectively, matching lab-based
measurement performance at a higher sensitivity than the human
eye.
ams is honored to participate in the EUREKA funding program and
join the Federal Ministries in the fight against the pandemic.
EUREKA is the world's biggest public network for international
cooperation in R&D and innovation, present in over 45 countries
via national funding agencies.
Unique new digital LFT solution has speed, access, and cost
advantages over PCR testing
Current PCR testing needs expansive labs with many logistic and
handling steps, which can result in restricted capacity leading to
slow results to patients and high-cost tests. In addition, the
uncomfortable but necessary nasal testing swab process requires
trained staff. ams will offer technology for an approximate
15-minute rapid test solution to enable a fast, cost-efficient,
highly-accurate, and cloud-connected LFT which uses saliva to
detect antigen and blood to detect antibody for the SARS-CoV-2
(COVID-19) virus.
"The unique digital LFT solution from ams and our partners is a
rapid, saliva-based antigen test which will become an essential
critical weapon in the fight to resume the many economic and social
activities that comprise what we call 'normal life.' The
availability of this EUR 586,000 funding -- EUR 314,000 Cov19Scan
and EUR 273,000 AntigenSense -- accelerates the development time to
bring the lateral flow test and cloud solution to market to fight
the SARS-CoV-2 (COVID-19) pandemic," says Jennifer Zhao, Executive
Vice President for the division Advanced Optical Sensors at
ams.
The cloud-connected rapid Lateral Flow Test solution from ams
and its partners can be produced at scale to support wide-spread
availability. The solution digitizes the result from the lateral
flow test strips eliminating complicated logistics and clinical
processing. The data is immediately available in a digital format
and can be uploaded to national or global monitoring systems if
desired.
Connected to secure medical services
The digital LFT cartridge will send encrypted data together with
a unique test ID to a digital app on the user's smartphone. The app
will act as a user guide and provide encrypted data transfer to a
medical-grade, secure cloud including user information and
geographical position. This secure cloud will analyze the data
based on a lot-specific ID. The result can be sent to the user and
also healthcare services enabling pandemic control. Supported
standards include all software components being based on
IEC-62304*, GDPR and HIPAA cybersecurity, in addition to data
storage requirements.
For more information on ams' AS7341L spectral sensor please go
to https://ams.com/AS7341L
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201201005556/en/
CONTACT: Amy Flécher
ams AG
VP Marketing Communications
press@ams.com
ams.com
SOURCE: ams
Copyright Business Wire 2020
(END) Dow Jones Newswires
December 01, 2020 11:15 ET (16:15 GMT)